Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XLase Plus

K-Number: K212790 · 2022-08-15

Decision Date2022-08-15
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

XLase Plus is a medical device manufactured by Biotec Italia, Srl. It received FDA 510(k) clearance on 2022-08-15 under approval number K212790. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XLase Plus?

XLase Plus is a medical device that received FDA 510(k) clearance on 2022-08-15. It is manufactured by Biotec Italia, Srl. The 510(k) number is K212790.

When was XLase Plus approved by the FDA?

XLase Plus received FDA 510(k) clearance on 2022-08-15, under approval number K212790.

What company makes XLase Plus?

XLase Plus is manufactured by Biotec Italia, Srl.

What is the FDA product code for XLase Plus?

The FDA product code for XLase Plus is GEX. This falls under the Gastroenterology category.

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.